|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.80 EUR | -1.82% |
|
-7.69% | -28.62% |
| 07-17 | EyePoint Pharmaceuticals Agrees to Settle US False Claims Act Allegations | MT |
| 07-16 | Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EYEPOINT, INC. | Other Pharmaceuticals | -1.82% | -7.69% | -28.62% | +23.37% | +52.11% | 1.06B |
-
|
-
|
-
|
- Stock Market
- Stocks
- EYPT Stock
- PV3B Stock
- Charts EyePoint, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
